A new non-hormonal contraceptive device for men
Official title: Development of ADAM Air: A Non-Hormonal Vas Occlusive Contraceptive Device
Funded at Contraline, INC. · NIH-10929569 · Data updated 2026-11-12
This study is testing a new, non-hormonal birth control option for men called ADAM Air, which involves a small implant that blocks sperm from being released, offering a safe and reversible way to prevent pregnancy.
Quick facts
| Grant type | Sbir 2 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Contraline, INC. NIH-funded |
| Lab location | 1 site (Charlottesville, United States) |
| Project start | September 10, 2024 |
| Project end | August 31, 2025 |
| Funding year | 2024 |
| Award (this year) | $291,440 |
| NIH project number | 1R44HD115509-01 |
| Project ID | NIH-10929569 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are men seeking a non-hormonal contraceptive method.
✕Less likely to help
Patients who are not male or those who do not wish to use a contraceptive method will not benefit from this research.
What this research studies
This research focuses on developing ADAM Air, a non-hormonal contraceptive device designed for men. It involves implanting an aerogel into the vas deferens, which then swells to block sperm from reaching the ejaculatory duct. This innovative approach aims to provide a long-lasting and reversible contraceptive option, addressing the need for more male contraceptive methods. The study builds on previous findings that demonstrated the safety and efficacy of the first-generation ADAM device.
Why it matters
Potential benefit: If successful, this research could provide men with a reliable and reversible contraceptive option, potentially reducing unintended pregnancies.
How similar studies have gone: Previous studies on the first-generation ADAM device have shown promising results, indicating that this new approach may also be effective.
Where this research is happening
-
Contraline, INC.
Charlottesville, United States Active
Researchers
- Principal investigator: Tropsha, Yelena — Contraline, INC.
- Study coordinator: Tropsha, Yelena
Related research
Other NIH-funded projects on the same topics.
-
ADAM Air: a removable, on-demand vas occlusive device for men
A new, reversible male contraception option uses a swelling hydrogel implanted in the vas deferens to block sperm, offering on-demand reversal.
-
ADAM Air — a non-hormonal male contraceptive implant
ADAM Air is a non-hormonal implant placed in the vas deferens to block sperm and give men long-lasting, reversible contraception.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.